Figure 3From: Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy Prevalence in each cycle of the most frequently mentioned adverse events (> 2% of the subjects).Back to article page